EFFICACY OF A FIXED PEPPERMINT OIL CARAWAY OIL COMBINATION IN NONULCER DYSPEPSIA

Citation
B. May et al., EFFICACY OF A FIXED PEPPERMINT OIL CARAWAY OIL COMBINATION IN NONULCER DYSPEPSIA, Arzneimittel-Forschung, 46(12), 1996, pp. 1149-1153
Citations number
23
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
00044172
Volume
46
Issue
12
Year of publication
1996
Pages
1149 - 1153
Database
ISI
SICI code
0004-4172(1996)46:12<1149:EOAFPO>2.0.ZU;2-5
Abstract
The efficacy and safety of the standardized herbal combination prepara tion Enteroplant(R), consisting of peppermint oil (90 mg) and caraway oil (50 mg) in an enteric coated capsule, have been studied in a doubl e-blind, placebo-controlled multicentre trial in patients with non-ulc er dyspepsia. A total of 45 patients were included in the trial after thorough physical and gastro-enterological examination. The primary ou tcome variables were the change in the intensity of pain and the globa l clinical impression (Clinical Global Impressions [CGI], Item 2), whi ch were evaluated for 39 patients (test preparation: 19, placebo: 20). After four weeks of treatment both target parameters were significant ly improved for the group of patients treated with the peppermint oil/ caraway oil combination compared to the placebo group (p = 0.015 and 0 .008, respectively). Before the start of treatment all patients in the test preparation group reported moderate to severe pain, while by the end of the study 63.2 % od these patients were free from pain. The pa in symptoms had improved in a total of 89.5 % of the patients in the a ctive treatment group. After 4 weeks the Clinical Global Impressions w ere improved for 94.5 % of the patients treated with the peppermint oi l/caraway oil combination. The trial medication was also superior to p lacebo with respect to pain frequency, medical prognosis, the severity of the disorder and the efficacy index (CGI, Items 1 and 3), which we re adopted as secondary end-points for evaluation of efficacy. There w ere similarly favourable findings for the herbal combination, compared with placebo, with respect to the reduction of other gastrointestinal symptoms. The combination preparation was found to be excellently tol erated. There was a total of 7 adverse events (test preparation: 4, pl acebo: 3), with a causal association with the treatment being ascribed in one case for the test preparation group and one case for the place bo group.